重点产品
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 25076 | HC-7366 | 2803470-63-3 | ≧98.0% |  |
| HC-7366 is a potent and selective activator of the general control nonderepressible 2 | ||||
| 41788 | CB-6644 | 2316817-88-4 | 96.33% |  |
| CB-6644 acts as a noncompetitive ATPase inhibitor. Additionally, it can inhibit RUVBL | ||||
| 25148 | Atebimetinib | 2669009-92-9 | ≧98.0% |  |
| 阿替美替尼（IMM-1-104）是一种口服的小分子MEK1和MEK2激酶变构抑制 | ||||
| 25075 | LLL12 | 1260247-42-4 | ≧97.0% |  |
| LLL12是一种强效的STAT3抑制剂。LLL12在小鼠异种移植物模型中显示出 | ||||
| 181121 | AZD-5904 | 618913-30-7 | ≧98.0% |  |
| AZD5904是一个有效的口服生物利用率MPO抑制剂。在临床前研究中,AZ | ||||
| 237071 | Flavopiridol ( 夫拉平度 ) | 146426-40-6 | ≧98.0% | .png) |
| Alvocidib is a synthetic dihydroxyflavone that is 5,7-dihydroxyflavone which is subst | ||||
| 24107 | LXH-3-71 | 2251753-65-6 | ≧97.0% |  |
| LXH-3-71是一种新型“分子胶”，可诱导PHGDH和DDB1-CUL4泛素连接酶之 | ||||
| 20509 | GLPG3667 | 2308520-97-8 | ≧98.0% |  |
| GLPG3667 是一种口服强效选择性小分子 TYK2 抑制剂，正在开发用于治 | ||||
| 121431 | KW-2478 | 819812-04-9 | 98% |  |
| KW-2478 是一种针对人类热休克蛋白 90 (Hsp90) 的药物，具有潜在的抗 | ||||
| 18576 | VU0467154 | 1451993-15-9 | ≧98.0% |  |
| VU0467154 is a positive allosteric modulator of theM4 muscarinic acetylcholine recept | ||||
| 171452 | BGB 15025 ; BGB-15025 ; BGB15025 | 2766481-17-6 | ≧98.0% |  |
| BGB-15025 是一种有效的选择性 HPK1 抑制剂，在多种肿瘤模型中作为 | ||||
| 17021601 | LY3039478 ( Crenigacestat ) | 1421438-81-4 | ≧98.0% | _1421438-81-4.png) |
| LY3039478 ( Crenigacestat ) 是一种选择性 NOTCH1 抑制剂，通过阻断 VEGFA/ | ||||